A firm called Company RadioMedic Ltd., developed at the Nuclear Physics Institute of the ASCR in 2009, deals with the development, manufacturing and distribu‑ tion of radiopharmaceutical preparations. It has developed a ra-diopharmaceutical with an active substance that selectively binds to hypoxic cells. These tumor cells are more sensitive to radiotherapy and chemotherapy in the presence of oxygen in tissue and consequently the number of the hypoxic cells is a limiting factor for a therapy effect. and František Melichar.
The International Workshop on Astronomical X-Ray Optics took place in Prague December 6-12,2009. Its goal was to present and to discuss recent and forthcoming technologies for future X-ray astronomy missions, with emphasis on IXO of ESA/NASA/JAXA. These missions require development of mostly innovative techno logies, and invited speakers discussed the possibilities, results obtained so far, and new ideas in detail. and Martin Blažek.
The General Assembly of the International Association of Research Institutes (RIHA) took place at the Institute of Art History of the ASCR November 11–12, 2011. The purpose of RIHA (founded in 1998 in Paris) is to promote education and research in art history and related disciplines, to intensify cooperation between institutes by facilitating the flow of information on scientific and administrative activities and exchanging research findings while also encouraging institutes to undertake joint projects. The outcome of the Annual Assemblies of RIHA in Brussels (2010) and Prague (2011) is a Resolution of RIHA entitled Measuring Quality in Art History. and Lubomír Konečný.